查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
新生兒篩檢市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按產品類型、技術、測試類型、最終用戶和地理位置
市場調查報告書
商品編碼
1372496

新生兒篩檢市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按產品類型、技術、測試類型、最終用戶和地理位置

Newborn Screening Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type, Technology, Test Type, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 226 Pages | 訂單完成後即時交付

價格

全球新生兒篩檢市場預計將從 2022 年的 12.06 億美元增至 2030 年的 24.84 億美元。預計 2022 年至 2030 年該市場將以 9.4% 的年複合成長率成長。

推動市場的關鍵因素包括先天性疾病負擔的增加和新生兒疾病盛行率的增加。然而，世界各地新生兒篩檢政策和程序缺乏統一以及假陽性和假陰性結果阻礙了市場的成長。

新生兒篩檢市場的市場機會

隨著人們對疾病遺傳原因的認知不斷加深以及醫療保健技術的進步，對新生兒進行全面基因篩檢的需求正在增加。因此，新生兒篩檢市場的公司正在開發創新、經濟高效的篩檢解決方案。美國 FDA 於 2017 年批准 Kymriah 基因療法用於患有特殊類型急性淋巴細胞白血病的兒科患者。在這個治療過程中，編碼嵌合抗原受體的新基因被插入患者的 T 細胞中，刺激改變的 T 細胞追擊並摧毀白血病細胞。 Yescarta 和 Zynteglo 是大 B 細胞淋巴瘤和 BETA 地中海貧血的授權基因治療的另外兩個例子。此外，技術的出現賦予了識別出生時疾病遺傳傾向的能力，為個人化醫療保健鋪平了道路，與精準醫療的更廣泛趨勢保持一致。

孕期遺傳疾病篩檢的重點還在於及早發現與妊娠相關的問題。新一代定序有助於新生兒產前篩檢，檢測所有染色體的非整倍體（如唐氏症和 21 三體性）或部分染色體異常（重複或缺失）的敏感度超過 95%。螢光原位雜合技術（FISH）用於檢測鐮狀細胞性貧血等單基因疾病；它還有助於有效的植入前遺傳學診斷。使用母體血漿進行無細胞胎兒 DNA 等非侵入性操作是基因檢測的最新進展。胚胎 DNA 可以根據大小差異與母體 DNA 片段區分開來。使用螢光探針的即時 PCR、鳥槍定序（Solexa 或 Illumina）或大規模標靶平行定序可用於檢查與胎兒健康狀況相關的 DNA。如果進一步研究這種類型的基因篩檢，這將使醫生能夠透過某些藥物療法（藥物遺傳學）提供早期分子干涉，並在物理和化學上改造細胞、組織和器官。因此，嬰兒遺傳性疾病篩檢方法的進步為整個新生兒篩檢市場帶來了巨大的潛力。

阻礙新生兒篩檢市場的因素

不同國家篩檢條件清單的差異導致全球新生兒篩檢政策和實踐的不統一。有些國家對一系列疾病進行全面篩檢，而有些國家則專注於有限的一組疾病。這種差異為開發篩選測試和技術的公司帶來了障礙，因為他們需要針對特定市場修改其產品，這限制了規模經濟。此外，缺乏標準化協議可能會導致品質控制和資料收集實踐不一致。這導致篩檢結果不準確，並且難以比較地區之間的資料，使得研究人員和醫療保健提供者難以評估在研究地點實施的篩檢計畫的有效性。此外，缺乏通用標準使新生兒篩檢市場營運公司的監管環境變得複雜，因為他們需要專注於遵守複雜的法規網路以尋求不同國家的批准，這可能既耗時又昂貴。缺乏統一性還會阻礙國際合作和資料共享，限制新生兒篩檢研究和技術開發的潛力。因此，新生兒篩檢政策和程序缺乏統一限制了新生兒篩檢市場的進步。

新生兒篩檢市場：細分概述

新生兒篩檢市場依產品類型分為試劑、檢測試劑盒和儀器。 2022年，試劑和檢測試劑盒細分市場將佔據更大的市場佔有率，預計未來幾年將以最快的速度成長。新生兒篩檢的不同試劑和檢測試劑盒分為基於 DNA 的檢測、免疫檢測和酵素檢測。市場上的多家公司開發了一系列專門用於新生兒篩檢的試劑和檢測試劑盒。首先，Labsystems Diagnostics 推出了一種基於螢光微孔板的檢測方法，根據苯丙胺酸含量檢測新生兒苯丙胺酸 (PKU)，因為嬰兒苯丙胺酸水平升高會導致智力障礙。本公司提供的所有試劑盒均為手動模組化系統或全自動免持系統。

新生兒篩檢市場依技術分為串聯質譜（TMS）、分子測定、免疫測定和酵素測定、脈搏血氧飽和度篩檢技術和其他技術。 2022年，脈搏血氧儀篩檢技術領域佔據最大的市場佔有率。此外，免疫分析和酵素分析領域預計在未來幾年將成長最快。先天性心臟病（CCHD）是最常見的先天性殘疾之一，是一種導管依賴性先天性心臟病。它可能在產前和產後期間被發現，如果在新生兒期或嬰兒期未經診斷和治療，可能會危及生命。脈搏血氧儀篩檢用於檢測嬰兒的危重 CCHD。這是一種無痛、非侵入且經濟有效的嬰兒篩檢方法。脈搏血氧儀篩檢確定血液中氧飽和的血紅素百分比。

新生兒篩檢市場依測試類型分為乾血斑測試、聽力篩檢測試、危重先天性心臟病測試和其他測試。 2022年，血斑檢測領域佔據最大的市場佔有率。預計同一細分市場的新生兒篩檢市場在 2022 年至 2030 年期間將以顯著的年複合成長率成長。

新生兒篩檢市場按最終用戶分類為醫院、診所和診斷實驗室。 2022年，醫院和診所細分市場佔有更大的市場佔有率。然而，醫院和診所領域預計在 2022 年至 2030 年期間將以年複合成長率成長。醫療保健提供者在醫院的房間或新生兒/托兒所進行新生兒篩檢測試。預計未來幾年，醫院和診所將在新生兒篩檢市場中佔據更大佔有率，因為這些設施接受新生兒篩檢的患者人數最多。更好的設施、不同的治療選擇和良好的一站式護理吸引患者前往這些設施接受不同的診斷和治療程序。

新生兒篩檢市場：地理概況

近年來，北美新生兒篩檢市場經歷了顯著成長。隨著父母和醫療保健專業人員對早期篩檢對於識別和管理先天性疾病重要性的認知不斷提高，對新生兒篩檢服務的需求顯著增加。此外，醫療技術的進步對於增強新生兒篩檢能力至關重要——實驗室自動化提高了篩檢的準確性、速度和成本效益。這使得醫療專業人員能夠提供全面的新生兒篩檢，涵蓋更廣泛的遺傳和代謝疾病。有利的立法和監管措施也有利於北美的新生兒篩檢市場。許多州和省已經實施了強制性新生兒篩檢計劃，確保所有嬰兒在出生後不久就接受篩檢。例如，美國每個州都將新生兒篩檢作為公共衛生計劃；每年，約有 400 萬名嬰兒根據該計劃接受篩檢，檢查是否患有分娩時不常出現的疾病。德州衛生與公共服務部於 2021 年 6 月開始對新生兒進行脊髓性肌肉萎縮症 (SMA) 篩檢。

A few of the major primary and secondary sources referred to while preparing the report on the newborn screening market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (世界衛生組織).

目錄

第 1 章：簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：新生兒篩檢市場格局

  • 概述
  • PEST分析
    • 全球PEST分析

第 5 章：新生兒篩檢市場 - 主要產業動態

  • 主要市場促進因素
    • 政府為新生兒篩檢提供的資金激增
    • 先天性疾病負擔不斷增加
    • 新生兒疾病盛行率不斷增加
  • 主要市場限制
    • 新生兒篩檢政策和實踐缺乏統一
  • 主要市場機會
    • 新生兒基因篩檢
  • 未來的趨勢
    • 機器學習和人工智慧在篩檢中的整合
  • 影響分析：

第 6 章：新生兒篩檢市場 - 全球市場分析

  • 新生兒篩檢市場收入，2022 - 2030

第 7 章：全球新生兒篩檢市場 - 2030 年收入和預測 - 按產品類型

  • 概述
  • 2022 年及 2030 年新生兒篩檢市場收入佔有率，依產品類型分類 (%)
  • 試劑和檢測試劑盒
  • 儀器

第 8 章：全球新生兒篩檢市場 - 收入和 2030 年預測 - 按技術分類

  • 概述
  • 2022 年和 2030 年按技術分類的新生兒篩檢市場收入佔有率 (%)
  • 串聯質譜 (TMS)
  • 分子檢測
  • 免疫測定和酵素測定
  • 脈搏血氧篩檢技術
  • 其他技術

第 9 章：全球新生兒篩檢市場 - 收入和 2030 年預測 - 按測試類型

  • 概述
  • 2022 年和 2030 年按測試類型分類的新生兒篩檢市場收入佔有率 (%)
  • 乾血斑測試
  • 聽力篩檢測試
  • 嚴重先天性心臟病 (CCHD) 測試
  • 其他測試類型

第 10 章：全球新生兒篩檢市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年新生兒篩檢市場收入佔有率（按最終用戶分類）（%）
  • 醫院和診所
  • 診斷實驗室

第 11 章：新生兒篩檢市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 12 章：新生兒篩檢市場-產業格局

  • 概述
  • 新生兒篩檢市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 13 章：公司簡介

  • LifeCell International Pvt Ltd
  • Zentech SA
  • Trivitron Healthcare Pvt Ltd
  • PerkinElmer Inc
  • Waters Corp
  • Bio-Rad Laboratories Inc
  • Masimo Corp
  • Natus Medical Inc.
  • Baebies Inc
  • MRC Holland BV
  • Medtronic Plc

第 14 章：附錄

  • 關於我們
  • 專業術語
Product Code: TIPHE100001294

The global newborn screening market is expected to reach US$ 2.484 billion in 2030 from US$ 1.206 billion in 2022. The market is estimated to grow with a CAGR of 9.4% from 2022 to 2030.

The key factors driving the market include rising burden of congenital diseases and increasing prevalence of newborn disorders. However, lack of uniformity of newborn screening policies and procedures across the world and false positive and false negative results hinders the market growth.

Market Opportunities of Newborn Screening Market

The demand for comprehensive genetic screening of newborns is rising with the deepening knowledge about the genetic causes of medical conditions and advancements in healthcare technologies. As a result, companies in the newborn screening market are developing innovative, cost-effective screening solutions. The US FDA licensed the Kymriah gene therapy in 2017 for use in pediatric patients with a particular kind of acute lymphoblastic leukemia. During this therapy, a new gene that codes for a chimeric antigen receptor is inserted into the patient's T cells, stimulating the altered T cells to go after and destroy the leukemic cells. Yescarta and Zynteglo are two more examples of authorized gene treatments for large B-cell lymphoma and beta-thalassemia. Further, the emergence of technologies conferring an ability to identify genetic predispositions to diseases at birth pave the way for personalized healthcare, aligning with the broader trend of precision medicine.

Screening for genetic diseases during pregnancy also focuses on the early detection of pregnancy-related problems. Next-generation sequencing aids in the prenatal screening of neonates with a sensitivity of above 95% for detecting aneuploidies (such as Down syndrome and Trisomy 21) or partial chromosomal abnormalities (duplications or deletions) in all chromosomes. Fluorescence in-situ hybridization (FISH) is employed to detect monogenic illnesses such as sickle cell anemia; it also aids in an effective preimplantation genetic diagnosis. Noninvasive procedures such as the cell-free fetal DNA approach using maternal plasma are the recent advancements in genetic tests. The embryonic DNA can be distinguished from maternal DNA pieces based on differences in their sizes. Real-time PCR with fluorescent probes, shotgun sequencing (Solexa or Illumina), or huge targeted parallel sequencing can be used to examine DNA associated with fetal medical conditions. This would allow doctors to provide early molecular interventions with certain pharmacological therapies (pharmacogenetics) and to transform cells, tissues, and organs physically and chemically if this type of genetic screening is further researched. Thus, advancements in methods for screening infants for genetic disorders hold immense potential for the overall newborn screening market.

Factors Hampering Newborn Screening Market

Variations regarding the list of conditions screened for in different countries result in non-uniformity in newborn screening policies and practices worldwide. A few nations screen for a comprehensive range of disorders, while others focus on a limited set. This difference creates barriers for companies developing screening tests and technologies, as they need to modify their products to specific markets, limiting economies of scale. Moreover, the lack of standardized protocols can result in inconsistent quality control and data collection practices. This leads to inaccuracies in screening results and difficulties in comparing data between regions, making it challenging for researchers and healthcare providers to assess the effectiveness of screening programs implemented in localities understudy. Additionally, the absence of universal standards complicates the regulatory landscape for companies operating in the newborn screening market, as they need to focus on complying with a complex web of regulations for seeking approvals in different countries, which can be time-consuming and expensive. The lack of uniformity can also hinder international collaborations and data sharing, limiting the potential of newborn screening research and technology development. Thus, the lack of uniformity in newborn screening policies and procedures limits the progress of the newborn screening market.

Newborn Screening Market: Segmental Overview

The newborn screening market, by product type, is segmented into reagents and assay kits and instruments. In 2022, the reagents and assay kits segment held a larger market share and is expected to grow at the fastest rate in the coming years. Different reagents and assay kits for newborn screening are categorized into DNA-based assays, immunoassays, and enzymatic assays. Various companies in the market have developed a range of reagents and assay kits specifically for neonatal screening. Firstly, Labsystems Diagnostics launched a fluorometric microplate-based assay for detecting phenylketonuria (PKU) in newborns based on phenylalanine content, as increasing the phenylalanine level in the baby can cause intellectual disability. All the reagent kits offered by the Company are manual modular systems or fully automated hands-off systems.

The newborn screening market, by technology, is segmented into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assays, pulse oximetry screening technology, and other technologies. In 2022, the pulse oximetry screening technology segment held the largest share of the market. Moreover, the immunoassays and enzymatic assays segment is expected to grow fastest during the coming years. Congenital heart disease (CCHD), one of the most common congenital disabilities, is a duct-dependent congenital heart disease. It may be detected during the prenatal and postnatal period, while it can be life-threatening if it goes undiagnosed and untreated in the neonatal period or infancy. Pulse oximetry screening is used to detect critical CCHD in infants. It is a painless, noninvasive, and cost-effective method of screening infants. The pulse oximeter screening determines the percentage of hemoglobin in the blood saturated with oxygen.

The newborn screening market, by test type, is segmented into dry blood spot tests, hearing screen tests, critical congenital heart disease tests, and other tests. In 2022, the blood spot test segment held the largest share of the market. The newborn screening market for the same segment is estimated to grow at a significant CAGR during 2022 -2030.

The newborn screening market, by end-user, is segmented into hospitals, clinics, and diagnostic laboratories. In 2022, the hospitals and clinics segment held a larger market share. However, the hospitals and clinics segment is estimated to grow at a CAGR during 2022-2030. healthcare provider performs newborn screening tests in a room or a newborn/nursery area at hospitals. The hospitals and clinics segment is projected to hold a larger share of the newborn screening market in the coming years as these facilities receive maximum patient footfall for newborn baby screening. Better facilities, and the availability of different treatment options and good nursing care under one roof attract patients toward these facilities for different diagnostic and therapeutic procedure.

Newborn Screening Market: Geographical Overview

The newborn screening market in North America has experienced significant growth in recent years. The demand for newborn screening services has increased significantly with the surging awareness among parents and healthcare professionals about the importance of early screening for identifying and managing congenital disorders. Additionally, improvements in medical technology have been crucial in enhancing newborn screening capabilities-laboratory automation has boosted screening accuracy, speed, and cost-effectiveness. This has made it possible for medical professionals to give thorough newborn screening panels that cover a larger spectrum of genetic and metabolic disorders. Favorable legislation and regulatory measures also benefit the newborn screening market in North America. Many states and provinces have implemented mandatory newborn screening programs, ensuring all infants are screened shortly after birth. For instance, every state in the US offers newborn screening as a public health program; yearly, ~4 million babies are screened under this program for illnesses that aren't often present at the time of delivery. The Texas Department of Health and Human Services began screening newborns for Spinal Muscular Atrophy (SMA) in June 2021.

A few of the major primary and secondary sources referred to while preparing the report on the newborn screening market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the newborn screening market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global newborn screening market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the newborn screening market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Newborn Screening Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. Newborn Screening Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Surging Government Funding for Newborn Screening
    • 5.1.2 Rising Burden of Congenital Diseases
    • 5.1.3 Increasing Prevalence of Newborn Disorders
  • 5.2 Key Market Restraints
    • 5.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
  • 5.3 Key Market Opportunities
    • 5.3.1 Genetic Screening of Newborns
  • 5.4 Future Trends
    • 5.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
  • 5.5 Impact Analysis:

6. Newborn Screening Market - Global Market Analysis

  • 6.1 Newborn Screening Market Revenue (US$ Mn), 2022 - 2030

7. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Product Type

  • 7.1 Overview
  • 7.2 Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • 7.3 Reagents and Assay Kits
    • 7.3.1 Overview
    • 7.3.2 Reagents and Assay Kits: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 Global Newborn Screening Market, by Reagents and Assay Kits, 2020-2030 (US$ Million)
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 Global Newborn Screening Market, by Instruments, 2020-2030 (US$ Million)

8. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Tandem Mass Spectrometry (TMS)
    • 8.3.1 Overview
    • 8.3.2 Tandem Mass Spectrometry (TMS): Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Molecular Assays
    • 8.4.1 Overview
    • 8.4.2 Molecular Assays: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Immunoassays and Enzymatic Assays
    • 8.5.1 Overview
    • 8.5.2 Immunoassays and Enzymatic Assays: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Pulse Oximetry Screening Technology
    • 8.6.1 Overview
    • 8.6.2 Pulse Oximetry Screening Technology: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Other Technologies
    • 8.7.1 Overview
    • 8.7.2 Other Technologies: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Test Type

  • 9.1 Overview
  • 9.2 Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 9.3 Dry Blood Spot Test
    • 9.3.1 Overview
    • 9.3.2 Dry Blood Spot Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Hearing Screen Test
    • 9.4.1 Overview
    • 9.4.2 Hearing Screen Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Critical Congenital Heart Diseases (CCHD) Test
    • 9.5.1 Overview
    • 9.5.2 Critical Congenital Heart Diseases (CCHD) Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Other Test Types
    • 9.6.1 Overview
    • 9.6.2 Other Test Types: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

10. Global Newborn Screening Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • 10.3 Hospitals and Clinics
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Clinics: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Diagnostic Laboratories
    • 10.4.1 Overview
    • 10.4.2 Diagnostic Laboratories: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

11. Newborn Screening Market - Geographical Analysis

  • 11.1 North America Newborn Screening Market, Revenue and Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 North America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.3 North America: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
      • 11.1.3.1 North America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
      • 11.1.3.2 North America: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    • 11.1.4 North America: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    • 11.1.5 North America: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    • 11.1.6 North America: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.6.1 North America Newborn Screening Market, by Country
      • 11.1.6.2 US
        • 11.1.6.2.1 US Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.6.2.2 US: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.2.2.1 US: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.2.2.2 US: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.2.3 US: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.1.6.2.4 US: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.6.2.5 US: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.6.3 Canada
        • 11.1.6.3.1 Canada Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.6.3.2 Canada: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.3.2.1 Canada: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.3.2.2 Canada: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.3.3 Canada: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.1.6.3.4 Canada: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.6.3.5 Canada: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.6.4 Mexico
        • 11.1.6.4.1 Mexico Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.6.4.2 Mexico: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.4.2.1 Mexico: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.4.2.2 Mexico: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.4.3 Mexico: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.1.6.4.4 Mexico: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.6.4.5 Mexico: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  • 11.2 Europe Newborn Screening Market, Revenue and Forecast to 2030
    • 11.2.1 Overview
    • 11.2.2 Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.3 Europe: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
      • 11.2.3.1 Europe: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
      • 11.2.3.2 Europe: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    • 11.2.4 Europe: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    • 11.2.5 Europe: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    • 11.2.6 Europe: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.1 Europe Newborn Screening Market, by Country
      • 11.2.6.2 UK
        • 11.2.6.2.1 UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.2.2 UK: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.2.2.1 UK: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.2.2.2 UK: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.2.3 UK: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.6.2.4 UK: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.6.2.5 UK: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.3 Germany
        • 11.2.6.3.1 Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.3.2 Germany: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.3.2.1 Germany: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.3.2.2 Germany: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.3.3 Germany: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.6.3.4 Germany: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.6.3.5 Germany: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.4 France
        • 11.2.6.4.1 France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.4.2 France: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.4.2.1 France: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.4.2.2 France: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.4.3 France: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.6.4.4 France: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.6.4.5 France: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.5 Italy
        • 11.2.6.5.1 Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.5.2 Italy: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.5.2.1 Italy: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.5.2.2 Italy: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.5.3 Italy: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.6.5.4 Italy: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.6.5.5 Italy: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.6 Spain
        • 11.2.6.6.1 Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.6.2 Spain: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.6.2.1 Spain: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.6.2.2 Spain: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.6.3 Spain: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.6.6.4 Spain: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.6.6.5 Spain: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.7 Rest of Europe
        • 11.2.6.7.1 Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.7.2 Rest of Europe: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.7.2.1 Rest of Europe: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.7.2.2 Rest of Europe: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.7.3 Rest of Europe: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.6.7.4 Rest of Europe: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.6.7.5 Rest of Europe: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  • 11.3 Asia Pacific Newborn Screening Market, Revenue and Forecast to 2030
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.3 Asia Pacific: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
      • 11.3.3.1 Asia Pacific: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
      • 11.3.3.2 Asia Pacific: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    • 11.3.4 Asia Pacific: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    • 11.3.5 Asia Pacific: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    • 11.3.6 Asia Pacific: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.1 Asia Pacific Newborn Screening Market, by Country
      • 11.3.6.2 China
        • 11.3.6.2.1 China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.2.2 China: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.2.2.1 China: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.2.2.2 China: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.2.3 China: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.6.2.4 China: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.6.2.5 China: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.3 Japan
        • 11.3.6.3.1 Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.3.2 Japan: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.3.2.1 Japan: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.3.2.2 Japan: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.3.3 Japan: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.6.3.4 Japan: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.6.3.5 Japan: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.4 India
        • 11.3.6.4.1 India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.4.2 India: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.4.2.1 India: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.4.2.2 India: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.4.3 India: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.6.4.4 India: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.6.4.5 India: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.5 Australia
        • 11.3.6.5.1 Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.5.2 Australia: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.5.2.1 Australia: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.5.2.2 Australia: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.5.3 Australia: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.6.5.4 Australia: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.6.5.5 Australia: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.6 South Korea
        • 11.3.6.6.1 South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.6.2 South Korea: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.6.2.1 South Korea: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.6.2.2 South Korea: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.6.3 South Korea: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.6.6.4 South Korea: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.6.6.5 South Korea: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.7 Rest of Asia Pacific
        • 11.3.6.7.1 Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.7.2 Rest of Asia Pacific: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.7.2.1 Rest of Asia Pacific: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.7.2.2 Rest of Asia Pacific: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.7.3 Rest of Asia Pacific: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.6.7.4 Rest of Asia Pacific: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.6.7.5 Rest of Asia Pacific: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  • 11.4 Middle East & Africa Newborn Screening Market, Revenue and Forecast to 2030
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.3 Middle East & Africa: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
      • 11.4.3.1 Middle East & Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
      • 11.4.3.2 Middle East & Africa: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    • 11.4.4 Middle East & Africa: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    • 11.4.5 Middle East & Africa: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    • 11.4.6 Middle East & Africa: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.4.6.1 Middle East & Africa Newborn Screening Market, by Country
      • 11.4.6.2 Saudi Arabia
        • 11.4.6.2.1 Saudi Arabia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.2.2 Saudi Arabia: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.2.2.1 Saudi Arabia: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.2.2.2 Saudi Arabia: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.2.3 Saudi Arabia: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.6.2.4 Saudi Arabia: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.4.6.2.5 Saudi Arabia: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.4.6.3 UAE
        • 11.4.6.3.1 UAE Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.3.2 UAE: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.3.2.1 UAE: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.3.2.2 UAE: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.3.3 UAE: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.6.3.4 UAE: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.4.6.3.5 UAE: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.4.6.4 South Africa
        • 11.4.6.4.1 South Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.4.2 South Africa: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.4.2.1 South Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.4.2.2 South Africa: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.4.3 South Africa: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.6.4.4 South Africa: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.4.6.4.5 South Africa: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.4.6.5 Rest of Middle East & Africa
        • 11.4.6.5.1 Rest of Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.5.2 Rest of Middle East & Africa: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.5.2.1 Rest of Middle East & Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.5.2.2 Rest of Middle East & Africa: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.5.3 Rest of Middle East & Africa: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.6.5.4 Rest of Middle East & Africa: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.4.6.5.5 Rest of Middle East & Africa: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  • 11.5 South & Central America Newborn Screening Market, Revenue and Forecast to 2030
    • 11.5.1 Overview
    • 11.5.2 South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.3 South & Central America: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
      • 11.5.3.1 South & Central America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
      • 11.5.3.2 South & Central America: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    • 11.5.4 South & Central America: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    • 11.5.5 South & Central America: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    • 11.5.6 South & Central America: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.5.6.1 South & Central America Newborn Screening Market, by Country
      • 11.5.6.2 Brazil
        • 11.5.6.2.1 Brazil Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.2.2 Brazil: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.2.2.1 Brazil: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.2.2.2 Brazil: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.2.3 Brazil: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.5.6.2.4 Brazil: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.5.6.2.5 Brazil: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.5.6.3 Argentina
        • 11.5.6.3.1 Argentina Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.3.2 Argentina: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.3.2.1 Argentina: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.3.2.2 Argentina: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.3.3 Argentina: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.5.6.3.4 Argentina: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.5.6.3.5 Argentina: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.5.6.4 Rest of South & Central America
        • 11.5.6.4.1 Rest of South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.4.2 Rest of South & Central America: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.4.2.1 Rest of South & Central America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.4.2.2 Rest of South & Central America: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.4.3 Rest of South & Central America: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.5.6.4.4 Rest of South & Central America: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.5.6.4.5 Rest of South & Central America: Newborn Screening Market, by End User, 2020-2030 (US$ Million)

12. Newborn Screening Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Newborn Screening Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 LifeCell International Pvt Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Zentech SA
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Trivitron Healthcare Pvt Ltd
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 PerkinElmer Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Waters Corp
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Bio-Rad Laboratories Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Masimo Corp
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Natus Medical Inc.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Baebies Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 MRC Holland BV
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Medtronic Plc
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Newborn Screening Market Segmentation
  • Table 2. Global Newborn Screening Market, by Reagents and Assay Kits - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Global Newborn Screening Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. North America Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. North America Newborn Screening Market, by Test Type- Revenue and Forecast to 2030 (US$ Million)
  • Table 9. North America Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. US Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. US Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. US Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. US Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. US Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Canada Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Canada Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Canada Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Canada Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Canada Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Canada Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Mexico Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Mexico Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Mexico Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Mexico Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Mexico Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Mexico Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Europe Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Europe Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Europe Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Europe Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Europe Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Europe Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. UK Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. UK Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. UK Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. UK Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. UK Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. UK Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Germany Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. Germany Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. Germany Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Germany Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. Germany Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. Germany Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. France Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. France Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. France Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. France Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. France Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. France Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. Italy Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Italy Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Italy Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Italy Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Italy Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Italy Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Spain Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Spain Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. Spain Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Spain Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. Spain Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Spain Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Rest of Europe Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. Rest of Europe Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. Rest of Europe Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. Rest of Europe Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. Rest of Europe Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Rest of Europe Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. Asia Pacific Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Asia Pacific Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Asia Pacific Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Asia Pacific Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. Asia Pacific Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. Asia Pacific Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. China Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. China Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. China Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. China Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. China Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. China Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Japan Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Japan Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Japan Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. Japan Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. Japan Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. Japan Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. India Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. India Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. India Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. India Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. India Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. India Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 94. Australia Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 95. Australia Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 96. Australia Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 97. Australia Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 98. Australia Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 99. Australia Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 100. South Korea Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 101. South Korea Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 102. South Korea Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 | (US$ Million)
  • Table 103. South Korea Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 104. South Korea Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 105. South Korea Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 106. Rest of Asia Pacific Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 107. Rest of Asia Pacific Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 108. Rest of Asia Pacific Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 109. Rest of Asia Pacific Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 110. Rest of Asia Pacific Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 111. Rest of Asia Pacific Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 112. Middle East & Africa Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 113. Middle East & Africa Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 114. Middle East & Africa Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 115. Middle East & Africa Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 116. Middle East & Africa Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 117. Middle East & Africa Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 118. Saudi Arabia Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 119. Saudi Arabia Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 120. Saudi Arabia Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 121. Saudi Arabia Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 122. Saudi Arabia Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 123. Saudi Arabia Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 124. UAE Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 125. UAE Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 126. UAE Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 127. UAE Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 128. UAE Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 129. UAE Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 130. South Africa Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 131. South Africa Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 132. South Africa Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 133. South Africa Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 134. South Africa Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 135. South Africa Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 136. Rest of Middle East & Africa Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 137. Rest of Middle East & Africa Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 138. Rest of Middle East & Africa Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 139. Rest of Middle East & Africa Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 140. Rest of Middle East & Africa Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 141. Rest of Middle East & Africa Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 142. South & Central America Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 143. South & Central America Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 144. South & Central America Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 145. South & Central America Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 146. South & Central America Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 147. South & Central America Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 148. Brazil Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 149. Brazil Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 150. Brazil Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 151. Brazil Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 152. Brazil Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 153. Brazil Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 154. Argentina Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 155. Argentina Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 156. Argentina Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 157. Argentina Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 158. Argentina Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 159. Argentina Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 160. Rest of South & Central America Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 161. Rest of South & Central America Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 162. Rest of South & Central America Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 163. Rest of South & Central America Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 164. Rest of South & Central America Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 165. Rest of South & Central America Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 166. Recent Organic Growth Strategies in Newborn Screening Market
  • Table 167. Recent Inorganic Growth Strategies in the Newborn Screening Market
  • Table 168. Glossary of Terms, Newborn Screening Market

List Of Figures

  • Figure 1. Newborn Screening Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Newborn Screening Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Newborn Screening Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Newborn Screening Market Revenue, Geography (US$ Mn), 2022 - 2030
  • Figure 7. Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • Figure 8. Reagents and Assay Kits: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Instruments: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 11. Tandem Mass Spectrometry (TMS): Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Molecular Assays: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Immunoassays and Enzymatic Assays: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Pulse Oximetry Screening Technology: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Other Technologies: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 17. Dry Blood Spot Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Hearing Screen Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Critical Congenital Heart Diseases (CCHD) Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Other Test Types: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 22. Hospitals and Clinics: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Diagnostic Laboratories: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. North America: Newborn Screening Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 25. North America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. North America Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 27. US Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Canada Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Mexico Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Europe Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 31. Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Europe Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 33. UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 38. Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. Asia Pacific Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 40. Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. Asia Pacific Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 42. China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 44. India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 46. South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. Middle East & Africa Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 49. Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 50. Middle East & Africa Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 51. Saudi Arabia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 52. UAE Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 53. South Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. Rest of Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. South & Central America Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 56. South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. South & Central America Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 58. Brazil Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. Argentina Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 60. Rest of South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. Growth Strategies in Newborn Screening Market